February 21, 2025 07:00 AM EST
Peer Review

Mer­ck KGaA tees up changes to lead­er­ship team; Ex-CVS Health CEO joins Ther­mo Fish­er’s board

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Max Bayer

Pharma Reporter

→ Pe­ter Guenter will re­tire as CEO of Mer­ck KGaA’s health­care busi­ness on June 1, one of sev­er­al per­son­nel moves that the Ger­man phar­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bel­gian biotech Au­gus­tine gets $85M for neu­ro and car­diometa­bol­ic pills

Teenag­er dies af­ter re­ceiv­ing Sarep­ta ther­a­py; Im­muno­vant gets Phase 3 win, but shifts fo­cus; Al­ny­lam’s big mo­ment; ...

Liv­er can­cer drug com­bo gets sec­ond FDA re­jec­tion over man­u­fac­tur­ing is­sues

Trump think tank res­ur­rects in­ter­na­tion­al drug pric­ing mod­el to go af­ter 'glob­al free­load­ing'

Al­ny­lam hopes its broad AT­TR-CM la­bel can give Amvut­tra an edge in heart dis­ease

BAR­DA can­cels an­nu­al bio­med­ical event for in­dus­try, gov­ern­ment reps

A service from the Financial Times